Recent developments in the field of diabetes treatment have introduced a promising class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that influences blood sugar levels. Among the most promising GLP-1 receptor agonists are semaglutide, t